Nasolacrimal Duct Obstruction
Nasolacrimal Duct Obstruction
Explore linked clinical trials. Standard reference: MESH:M0006556483 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Outcomes of Stentless Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction. | Nasolacrimal Duct Obstruction, excessive tearing, eye disorder, lacrimal apparatus disorder, lacrimal duct obstruction | Not yet recruiting | Not applicable | 2026-09-30 | NCT07848932 | |
| Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer | Head and Neck Neoplasms, Nasolacrimal Duct Obstruction, Neoplasms by Site, endocrine system disorder, eye disorder, lacrimal apparatus disorder, lacrimal duct obstruction, malignant endocrine neoplasm, neoplasm, thyroid gland disorder, thyroid tumor | Recruiting | Phase 3 | 2025-10-28 | NCT05999630 | |
| Effect of Standardized Lacrimal Sac Massage Compared With Probing for Congenital Lacrimal Duct Obstruction | Nasolacrimal Duct Obstruction, eye disorder, lacrimal apparatus disorder, lacrimal duct obstruction | Not yet recruiting | Not applicable | 2025-04-11 | NCT06924723 |